17 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28683645 | Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). | 2017 Oct | 2 |
2 | 26709605 | Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. | 2016 May | 2 |
3 | 26872331 | Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens. | 2016 | 4 |
4 | 24992294 | Atazanavir exposure is effective during pregnancy regardless of tenofovir use. | 2015 | 1 |
5 | 26196688 | Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa. | 2015 | 1 |
6 | 23843142 | [The progression of liver fibrosis in prison inmates co-infected by HIV and HCV who started on boosted protease inhibitor therapy]. | 2013 | 2 |
7 | 21239995 | Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. | 2011 Apr | 1 |
8 | 21692667 | Darunavir: an effective protease inhibitor for HIV-infected patients. | 2011 Jun | 1 |
9 | 21811554 | Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. | 2011 | 1 |
10 | 18474494 | Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. | 2008 Mar-Apr | 1 |
11 | 17594245 | Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent. | 2007 Jun | 1 |
12 | 15755851 | Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases. | 2005 Jul | 2 |
13 | 15983895 | Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patients. | 2005 Mar-Apr | 1 |
14 | 15090838 | Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients. | 2004 Jan 2 | 1 |
15 | 15220698 | The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir. | 2004 Aug 1 | 1 |
16 | 12444942 | Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. | 2002 Oct | 1 |
17 | 11134271 | Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir. | 2001 Jan | 2 |